J Zalewski

Predictive Effects of Circulating miR-221, miR-130a and miR-155 for Coronary Heart Disease: A Multi-Ethnic Study in China.

Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging

Uninterrupted oral anticoagulation versus bridging in patients with long-term oral anticoagulation during percutaneous coronary intervention: subgroup analysis from the WOEST trial

Antithrombotic Therapy for Venous Thromboembolic Disease

Acute ST-Segment Elevation Myocardial Infarction

Potential role for statins in sickle cell disease

Chronic inflammation in the etiology of disease across the life span

Increased plasma 8-iso-Prostaglandin F2α concentration in severe human traumatic brain injury

New strategies for the management of no-reflow after primary percutaneous coronary intervention

Cell Biology of Ischemia/Reperfusion Injury

Sickle-cell disease

Inflammation and thrombosis – testing the hypothesis with anti- inflammatory drug trials

Myocardial No-Reflow in Humans

Diagnostic Potential of Plasmatic MicroRNA Signatures in Stable and Unstable Angina

Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty

Extracellular Vesicles: How Drug and Pathology Interfere With Their Biogenesis and Function

Eicosapentaenoic acid and docosahexaenoic acid containing supplements modulate risk factors for cardiovascular disease: a meta‐analysis of randomised placebo‐control human clinical trials

Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus

The biology , function , and biomedical applications of exosomes

Hydroxyl radical-modified fibrinogen as a marker of thrombosis: the role of iron

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal

Gender-Specific Alterations in Fibrin Structure Function in Type 2 Diabetes: Associations with Cardiometabolic and Vascular Markers

Number of Microparticles Generated During Acute Myocardial Infarction and Stable Angina Correlates with Platelet Activation

Reduced clot permeability and susceptibility to lysis in patients with acute coronary syndrome: Effects of inflammation and oxidative stress

Prior simvastatin treatment is associated with reduced thrombin generation and platelet activation in patients with acute ST-segment elevation myocardial infarction

Antithrombotic management in patients with percutaneous coronary intervention requiring oral anticoagulation

Early abciximab administration before primary percutaneous coronary intervention improves infarct-related artery patency and left ventricular function in high-risk patients with anterior wall myocardial infarction: A randomized study

Elevated levels of 8-iso-prostaglandin F2α in acute coronary syndromes are associated with systemic and local platelet activation

No-Reflow Phenomenon After Acute Myocardial Infarction Is Associated With Reduced Clot Permeability and Susceptibility to Lysis

Reduced Thrombin Formation and Altered Fibrin Clot Properties Induced by Polyunsaturated Omega-3 Fatty Acids on Top of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention (OMEGA-PCI Clot)